Use of a triple helix-forming oligodeoxynucleotides as a novel therapeutic strategy for ERB-B2 positive breast cancer
Material type:
TextSeries: Staff Publications ; Staff Publications- Hollywood, DonalPublication details: 1998.DDC classification: - PUBLICATIONS ARCHIVE HOLL
| Item type | Current library | Home library | Shelving location | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
| 2 Week Loan | St. Luke’s Radiation Oncology Network Dublin | St. Luke’s Radiation Oncology Network Dublin | AR | PUBLICATIONS ARCHIVE HOLL (Browse shelf(Opens below)) | Available | 39015000020076 |
Total holds: 0
Browsing St. Luke’s Radiation Oncology Network Dublin shelves, Shelving location: AR Close shelf browser (Hides shelf browser)
| PUBLICATIONS ARCHIVE HOLL Successful outcome of patients with relapsed/refractory Hodgkin lymphoma treated with high dose chemotherapy at the National Adult Bone Marrow Transplant Unit at St Jamesu2019s Hospital | PUBLICATIONS ARCHIVE HOLL P35: Stem cell transplantation: the St. James's experience since 1984. | PUBLICATIONS ARCHIVE HOLL Examination of the potential of antisesse strategies in the treatment of CML | PUBLICATIONS ARCHIVE HOLL Use of a triple helix-forming oligodeoxynucleotides as a novel therapeutic strategy for ERB-B2 positive breast cancer | PUBLICATIONS ARCHIVE HOLL Integrating molecular oncology into the radiotherapy treatment process | PUBLICATIONS ARCHIVE HOLM Oncology in Ireland - the benefit from Telesynergy | PUBLICATIONS ARCHIVE LABS Incidence of Cervical Dyskaryosis in Ireland: Report of a Five-Year Audit |
Abstract of Poster Presentation. A print copy of this abstract is held in the Oncology Resource Centre.
There are no comments on this title.
Log in to your account to post a comment.